FDA approves new migraine-reducing technology

A new migraine technology may reduce the frequency of migraine headaches for those with chronic attacks.

Migraine sufferers may have a new way to reduce migraines without the intake of drugs.

The Food and Drug Administration (FDA) recently approved the Cefaly migraine technology, a headband-looking device that is worn over your forehead for no more than 20 minutes each day. The battery-powered device delivers small impulses to the nerves in the brain that may be key in migraines.

The device was developed by a company in Belgium. A trial published in the Journal of Neurology last month shows that the Cefaly device reduced the number of chronic migraine attacks on average, but the device was not shown to reduce the severity of the attacks.

The FDA said patients will need a prescription for the device.